Truist Financial Corp Amphastar Pharmaceuticals, Inc. Transaction History
Truist Financial Corp
- $62.7 Billion
- Q4 2024
A detailed history of Truist Financial Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 5,661 shares of AMPH stock, worth $175,604. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,661
Previous 5,725
1.12%
Holding current value
$175,604
Previous $277,000
24.19%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.1MCall Options Held
56.2KPut Options Held
3.5K-
Black Rock Inc. New York, NY5.94MShares$184 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$84.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$57.1 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$49.5 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$42.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.52B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...